KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
71 hedge funds and large institutions have $270M invested in Kinnate Biopharma Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
10% less funds holding
Funds holding: 79 → 71 (-8)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
71
Holding in Top 10
5
Calls
$277K
Puts
$74K
Top Buyers
| 1 | +$6.88M | |
| 2 | +$6.88M | |
| 3 | +$5.64M | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$1.35M |
| 5 |
Goldman Sachs
New York
|
+$922K |
Top Sellers
| 1 | -$2.76M | |
| 2 | -$1.96M | |
| 3 | -$825K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$433K |
| 5 |
BlackRock
New York
|
-$367K |